Weiss Ratings Reaffirms "Sell (D)" Rating for DocGo (NASDAQ:DCGO)

Key Points

• Weiss Ratings has reaffirmed a "Sell (D)" rating for DocGo (NASDAQ: DCGO), indicating concern regarding the company's stock performance.
• Canaccord Genuity raised DocGo's price target from $1.45 to $1.60 while assigning a "Hold" rating, reflecting a mixed outlook from analysts.
• DocGo shares are currently trading at $1.26, down 0.8%, with a market cap of $123.24 million and a negative earnings per share of ($0.11) reported recently.

DocGo (NASDAQ:DCGO - Get Free Report)'s stock had its "sell (d)" rating reiterated by research analysts at Weiss Ratings in a report released on Wednesday,Weiss Ratings reports.

Separately, Canaccord Genuity Group increased their price objective on DocGo from $1.45 to $1.60 and gave the stock a "hold" rating in a report on Thursday, August 21st. Two analysts have rated the stock with a Buy rating, three have given a Hold rating and one has given a Sell rating to the company's stock. According to data from MarketBeat, the stock presently has an average rating of "Hold" and a consensus target price of $3.24.

DocGo Stock Down 0.8%

Shares of DCGO traded down $0.01 during trading hours on Wednesday, reaching $1.26. The company's stock had a trading volume of 373,297 shares, compared to its average volume of 602,884. The firm has a market cap of $123.24 million, a price-to-earnings ratio of -6.63 and a beta of 0.95. DocGo has a 1-year low of $1.20 and a 1-year high of $5.68. The company has a 50 day moving average of $1.50 and a two-hundred day moving average of $1.72.

DocGo (NASDAQ:DCGO - Get Free Report) last issued its earnings results on Thursday, August 7th. The company reported ($0.11) earnings per share for the quarter, missing analysts' consensus estimates of ($0.06) by ($0.05). The business had revenue of $80.42 million during the quarter, compared to analyst estimates of $77.58 million. DocGo had a negative net margin of 4.20% and a negative return on equity of 3.26%. DocGo has set its FY 2025 guidance at EPS. As a group, analysts forecast that DocGo will post 0.25 EPS for the current fiscal year.

Institutional Investors Weigh In On DocGo

Large investors have recently added to or reduced their stakes in the stock. S Squared Technology LLC boosted its position in DocGo by 36.8% during the first quarter. S Squared Technology LLC now owns 1,890,976 shares of the company's stock worth $4,992,000 after purchasing an additional 508,590 shares during the period. Ritholtz Wealth Management bought a new stake in DocGo during the first quarter worth approximately $316,000. Punch & Associates Investment Management Inc. boosted its position in DocGo by 17.4% during the first quarter. Punch & Associates Investment Management Inc. now owns 2,201,667 shares of the company's stock worth $5,812,000 after purchasing an additional 325,760 shares during the period. Birchview Capital LP boosted its position in DocGo by 13.1% during the first quarter. Birchview Capital LP now owns 864,062 shares of the company's stock worth $2,281,000 after purchasing an additional 100,000 shares during the period. Finally, Nuveen LLC bought a new stake in DocGo during the first quarter worth approximately $649,000. Institutional investors own 56.44% of the company's stock.

DocGo Company Profile

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.